Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.

Publication

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry.

Journal Paper/Review - Sep 20, 2022

Wagner Benjamin, Hert Lisa, Polymeris Alexandros A, Schaedelin Sabine A, Lieb Johanna Maria, Seiffge David Julian, Traenka Christopher, Thilemann Sebastian, Fladt Joachim, Altersberger Valerian L, Zietz Annaelle, Dittrich Tolga, Fisch Urs, Gensicke Henrik, De Marchis Gian Marco, Bonati Leo H, Lyrer Philippe A, Engelter Stefan T, Peters Nils

Citation

Wagner B, Hert L, Polymeris A, Schaedelin S, Lieb J, Seiffge D, Traenka C, Thilemann S, Fladt J, Altersberger V, Zietz A, Dittrich T, Fisch U, Gensicke H, De Marchis G, Bonati L, Lyrer P, Engelter S, Peters N. Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry. Front Neurol 2022; 13:964723.

Type

Journal Paper/Review (English)

Journal

Front Neurol 2022; 13

Publication Date

Sep 20, 2022

Issn Print

1664-2295

Pages

964723

Brief description/objective

Cerebral microbleeds (CMBs) may have a differential impact on clinical outcome in stroke patients with atrial fibrillation (AF) treated with different types of oral anticoagulation (OAC).